var eventsData = [{"Ticker":"PCLN","EffectiveDate":"2017-01-20","Type":"RatingNeutral","Title":"MKM Partners initiates coverage on PCLN to Buy. Target Price is $1950.","DailyReturn":"0.38%","FiveDayReturnAfter":"2.71%","FiveDayReturnBefore":"0.18%"},{"Ticker":"PCLN","EffectiveDate":"2017-01-19","Type":"RatingNeutral","Title":"MKM Partners initiates coverage on PCLN to Buy. Target Price is $145.","DailyReturn":"-0.18%","FiveDayReturnAfter":"2.36%","FiveDayReturnBefore":"0.42%"},{"Ticker":"PCLN","EffectiveDate":"2017-01-10","Type":"RatingNeutral","Title":"Citigroup initiates coverage on PCLN to Buy.","DailyReturn":"0.36%","FiveDayReturnAfter":"0.68%","FiveDayReturnBefore":"4.24%"},{"Ticker":"PCLN","EffectiveDate":"2017-01-04","Type":"RatingNeutral","Title":"Needham initiates coverage on PCLN to Buy. Target Price is $1800.","DailyReturn":"0.65%","FiveDayReturnAfter":"3.82%","FiveDayReturnBefore":"-0.58%"},{"Ticker":"PCLN","EffectiveDate":"2016-12-08","Type":"RatingNeutral","Title":"CLSA initiates coverage on PCLN to Buy. Target Price is $1900.","DailyReturn":"1.41%","FiveDayReturnAfter":"0.09%","FiveDayReturnBefore":"1.54%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-10","Type":"RatingUpgrade","Title":"Stifel Nicolaus upgrades PCLN to Buy from Hold. Target Price is $1900; previously $1650.","DailyReturn":"-1.01%","FiveDayReturnAfter":"-4.36%","FiveDayReturnBefore":"8.29%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"JMP Securities maintains PCLN to Market Outperform. Target Price is $1776; previously $1560.","DailyReturn":"6.6%","FiveDayReturnAfter":"0.59%","FiveDayReturnBefore":"0.41%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $1790; previously $1750.","DailyReturn":"6.6%","FiveDayReturnAfter":"0.59%","FiveDayReturnBefore":"0.41%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Benchmark maintains PCLN to Buy. Target Price is $1800; previously $1600.","DailyReturn":"6.6%","FiveDayReturnAfter":"0.59%","FiveDayReturnBefore":"0.41%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $1750; previously $1560.","DailyReturn":"6.6%","FiveDayReturnAfter":"0.59%","FiveDayReturnBefore":"0.41%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Ascendiant Capital maintains PCLN to Buy. Target Price is $1700; previously $1600.","DailyReturn":"6.6%","FiveDayReturnAfter":"0.59%","FiveDayReturnBefore":"0.41%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Pacific Crest maintains PCLN to Sector Weight.","DailyReturn":"6.6%","FiveDayReturnAfter":"0.59%","FiveDayReturnBefore":"0.41%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Neutral. Target Price is $1600; previously $1400.","DailyReturn":"6.6%","FiveDayReturnAfter":"0.59%","FiveDayReturnBefore":"0.41%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $1800; previously $1700.","DailyReturn":"6.6%","FiveDayReturnAfter":"0.59%","FiveDayReturnBefore":"0.41%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"RBC Capital maintains PCLN to Outperform. Target Price is $1850; previously $1750.","DailyReturn":"6.6%","FiveDayReturnAfter":"0.59%","FiveDayReturnBefore":"0.41%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"UBS maintains PCLN to Neutral. Target Price is $1600.","DailyReturn":"6.6%","FiveDayReturnAfter":"0.59%","FiveDayReturnBefore":"0.41%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Wells Fargo maintains PCLN to Market Perform.","DailyReturn":"6.6%","FiveDayReturnAfter":"0.59%","FiveDayReturnBefore":"0.41%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingUpgrade","Title":"Barclays upgrades PCLN to Overweight. Target Price is $1750; previously $1550.","DailyReturn":"6.6%","FiveDayReturnAfter":"0.59%","FiveDayReturnBefore":"0.41%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-07","Type":"EarningsRevenueBeat","Title":"After market close, PCLN reports 2016 Q3's earning $31.18 per share and revenue $3691MM. This beats analyst's estimated EPS $29.51, beats estimated revenue $3620MM.","DailyReturn":"3.93%","FiveDayReturnAfter":"7.85%","FiveDayReturnBefore":"-3.48%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"3.93%","FiveDayReturnAfter":"7.85%","FiveDayReturnBefore":"-3.48%"},{"Ticker":"PCLN","EffectiveDate":"2016-11-07","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"3.93%","FiveDayReturnAfter":"7.85%","FiveDayReturnBefore":"-3.48%"},{"Ticker":"PCLN","EffectiveDate":"2016-10-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.47%","FiveDayReturnAfter":"-2.89%","FiveDayReturnBefore":"2.67%"},{"Ticker":"PCLN","EffectiveDate":"2016-10-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.47%","FiveDayReturnAfter":"-2.89%","FiveDayReturnBefore":"2.67%"},{"Ticker":"PCLN","EffectiveDate":"2016-09-08","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.12%","FiveDayReturnAfter":"-1.01%","FiveDayReturnBefore":"1.92%"},{"Ticker":"PCLN","EffectiveDate":"2016-08-18","Type":"RatingUpgrade","Title":"Evercore ISI Group upgrades PCLN to Buy from Hold. Target Price is $1650; previously $1350.","DailyReturn":"1.11%","FiveDayReturnAfter":"-1.19%","FiveDayReturnBefore":"1.47%"},{"Ticker":"PCLN","EffectiveDate":"2016-08-05","Type":"RatingNeutral","Title":"Barclays maintains PCLN to Overweight. Target Price is $1550; previously $1500.","DailyReturn":"3.98%","FiveDayReturnAfter":"3.39%","FiveDayReturnBefore":"2.52%"},{"Ticker":"PCLN","EffectiveDate":"2016-08-05","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Neutral. Target Price is $1400; previously $1250.","DailyReturn":"3.98%","FiveDayReturnAfter":"3.39%","FiveDayReturnBefore":"2.52%"},{"Ticker":"PCLN","EffectiveDate":"2016-08-05","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Hold. Target Price is $1450; previously $1330.","DailyReturn":"3.98%","FiveDayReturnAfter":"3.39%","FiveDayReturnBefore":"2.52%"},{"Ticker":"PCLN","EffectiveDate":"2016-08-05","Type":"RatingNeutral","Title":"UBS maintains PCLN to Buy. Target Price is $1600; previously $1475.","DailyReturn":"3.98%","FiveDayReturnAfter":"3.39%","FiveDayReturnBefore":"2.52%"},{"Ticker":"PCLN","EffectiveDate":"2016-08-05","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $1620; previously $1460.","DailyReturn":"3.98%","FiveDayReturnAfter":"3.39%","FiveDayReturnBefore":"2.52%"},{"Ticker":"PCLN","EffectiveDate":"2016-08-04","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"-0.81%","FiveDayReturnAfter":"2.53%","FiveDayReturnBefore":"3.46%"},{"Ticker":"PCLN","EffectiveDate":"2016-08-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.81%","FiveDayReturnAfter":"2.53%","FiveDayReturnBefore":"3.46%"},{"Ticker":"PCLN","EffectiveDate":"2016-08-04","Type":"EarningsBeatRevenueMiss","Title":"After market close, PCLN reports 2016 Q2's earning $13.93 per share and revenue $2556MM. This beats analyst's estimated EPS $12.69, misses estimated revenue $2580MM.","DailyReturn":"-0.81%","FiveDayReturnAfter":"2.53%","FiveDayReturnBefore":"3.46%"},{"Ticker":"PCLN","EffectiveDate":"2016-08-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.81%","FiveDayReturnAfter":"2.53%","FiveDayReturnBefore":"3.46%"},{"Ticker":"PCLN","EffectiveDate":"2016-06-30","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades PCLN to Overweight from Equal-Weight. Target Price is $1525; previously $1330.","DailyReturn":"0.72%","FiveDayReturnAfter":"4.56%","FiveDayReturnBefore":"-9.29%"},{"Ticker":"PCLN","EffectiveDate":"2016-06-22","Type":"RatingUpgrade","Title":"Barclays upgrades PCLN to Overweight from Equal-Weight. Target Price is $1500; previously $1300.","DailyReturn":"1.26%","FiveDayReturnAfter":"-10.9%","FiveDayReturnBefore":"2.94%"},{"Ticker":"PCLN","EffectiveDate":"2016-06-02","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.93%","FiveDayReturnAfter":"5.83%","FiveDayReturnBefore":"1.68%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.33%","FiveDayReturnAfter":"0.22%","FiveDayReturnBefore":"0%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-19","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.33%","FiveDayReturnAfter":"0.22%","FiveDayReturnBefore":"0%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-18","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-0.84%","FiveDayReturnAfter":"-1.68%","FiveDayReturnBefore":"0.76%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-18","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.84%","FiveDayReturnAfter":"-1.68%","FiveDayReturnBefore":"0.76%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.84%","FiveDayReturnAfter":"-1.68%","FiveDayReturnBefore":"0.76%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-13","Type":"RatingNeutral","Title":"Barclays maintains PCLN to Equal-Weight. Target Price is $1300; previously $1340.","DailyReturn":"-0.28%","FiveDayReturnAfter":"-2.52%","FiveDayReturnBefore":"3.28%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"JMP Securities maintains PCLN to Market Outperform. Target Price is $1420; previously $1500.","DailyReturn":"-0.97%","FiveDayReturnAfter":"1.13%","FiveDayReturnBefore":"-7.72%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $1510.","DailyReturn":"-0.97%","FiveDayReturnAfter":"1.13%","FiveDayReturnBefore":"-7.72%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Ascendiant Capital maintains PCLN to Buy. Target Price is $1600; previously $1625.","DailyReturn":"-0.97%","FiveDayReturnAfter":"1.13%","FiveDayReturnBefore":"-7.72%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $1660.","DailyReturn":"-0.97%","FiveDayReturnAfter":"1.13%","FiveDayReturnBefore":"-7.72%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $1525; previously $1550.","DailyReturn":"-0.97%","FiveDayReturnAfter":"1.13%","FiveDayReturnBefore":"-7.72%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"RBC Capital maintains PCLN to Outperform. Target Price is $1600; previously $1700.","DailyReturn":"-0.97%","FiveDayReturnAfter":"1.13%","FiveDayReturnBefore":"-7.72%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Oppenheimer maintains PCLN to Outperform. Target Price is $1420; previously $1460.","DailyReturn":"-0.97%","FiveDayReturnAfter":"1.13%","FiveDayReturnBefore":"-7.72%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $1580; previously $1600.","DailyReturn":"-0.97%","FiveDayReturnAfter":"1.13%","FiveDayReturnBefore":"-7.72%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Neutral. Target Price is $1250.","DailyReturn":"-0.97%","FiveDayReturnAfter":"1.13%","FiveDayReturnBefore":"-7.72%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Equal-Weight. Target Price is $1330.","DailyReturn":"-0.97%","FiveDayReturnAfter":"1.13%","FiveDayReturnBefore":"-7.72%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-7.5%","FiveDayReturnAfter":"-6.58%","FiveDayReturnBefore":"1.53%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-04","Type":"RatingNeutral","Title":"Guggenheim downgrades PCLN to Neutral from Buy.","DailyReturn":"-7.5%","FiveDayReturnAfter":"-6.58%","FiveDayReturnBefore":"1.53%"},{"Ticker":"PCLN","EffectiveDate":"2016-05-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-7.5%","FiveDayReturnAfter":"-6.58%","FiveDayReturnBefore":"1.53%"},{"Ticker":"PCLN","EffectiveDate":"2016-04-27","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"1.48%","FiveDayReturnAfter":"1.53%","FiveDayReturnBefore":"-0.88%"},{"Ticker":"PCLN","EffectiveDate":"2016-04-27","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.48%","FiveDayReturnAfter":"1.53%","FiveDayReturnBefore":"-0.88%"},{"Ticker":"PCLN","EffectiveDate":"2016-04-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.48%","FiveDayReturnAfter":"1.53%","FiveDayReturnBefore":"-0.88%"},{"Ticker":"PCLN","EffectiveDate":"2016-04-15","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.33%","FiveDayReturnAfter":"0.26%","FiveDayReturnBefore":"4.58%"},{"Ticker":"PCLN","EffectiveDate":"2016-03-31","Type":"RatingNeutral","Title":"Pacific Crest initiates coverage on PCLN to Sector Weight.","DailyReturn":"-2.13%","FiveDayReturnAfter":"-1.84%","FiveDayReturnBefore":"-0.18%"},{"Ticker":"PCLN","EffectiveDate":"2016-03-08","Type":"RatingNeutral","Title":"Moffett Nathanson initiates coverage on PCLN to Buy. Target Price is $1475.","DailyReturn":"-0.67%","FiveDayReturnAfter":"2.62%","FiveDayReturnBefore":"2.05%"},{"Ticker":"PCLN","EffectiveDate":"2016-03-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.4%","FiveDayReturnAfter":"-0.71%","FiveDayReturnBefore":"3.08%"},{"Ticker":"PCLN","EffectiveDate":"2016-03-04","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.4%","FiveDayReturnAfter":"-0.71%","FiveDayReturnBefore":"3.08%"},{"Ticker":"PCLN","EffectiveDate":"2016-02-18","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Hold. Target Price is $1350; previously $1333.","DailyReturn":"1.32%","FiveDayReturnAfter":"2.29%","FiveDayReturnBefore":"22.02%"},{"Ticker":"PCLN","EffectiveDate":"2016-02-18","Type":"RatingNeutral","Title":"Oppenheimer maintains PCLN to Outperform. Target Price is $1460; previously $1300.","DailyReturn":"1.32%","FiveDayReturnAfter":"2.29%","FiveDayReturnBefore":"22.02%"},{"Ticker":"PCLN","EffectiveDate":"2016-02-17","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"11.24%","FiveDayReturnAfter":"12.76%","FiveDayReturnBefore":"13.15%"},{"Ticker":"PCLN","EffectiveDate":"2016-02-17","Type":"EarningsRevenueBeat","Title":"Before market open, PCLN reports 2015 Q4's earning $12.63 per share and revenue $2000MM. This beats analyst's estimated EPS $11.84, beats estimated revenue $1960MM.","DailyReturn":"11.24%","FiveDayReturnAfter":"12.76%","FiveDayReturnBefore":"13.15%"},{"Ticker":"PCLN","EffectiveDate":"2016-02-17","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"11.24%","FiveDayReturnAfter":"12.76%","FiveDayReturnBefore":"13.15%"},{"Ticker":"PCLN","EffectiveDate":"2016-01-27","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Hold. Target Price is $1333; previously $1475.","DailyReturn":"-6.1%","FiveDayReturnAfter":"-4.1%","FiveDayReturnBefore":"1.54%"},{"Ticker":"PCLN","EffectiveDate":"2016-01-27","Type":"RatingNeutral","Title":"Goldman Sachs downgrades PCLN to Neutral from Buy.","DailyReturn":"-6.1%","FiveDayReturnAfter":"-4.1%","FiveDayReturnBefore":"1.54%"},{"Ticker":"PCLN","EffectiveDate":"2016-01-25","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on PCLN to Market Perform.","DailyReturn":"-1.8%","FiveDayReturnAfter":"-4.86%","FiveDayReturnBefore":"-0.29%"},{"Ticker":"PCLN","EffectiveDate":"2016-01-05","Type":"RatingNeutral","Title":"Raymond James downgrades PCLN to Outperform from Strong Buy.","DailyReturn":"-2.78%","FiveDayReturnAfter":"-9.16%","FiveDayReturnBefore":"-2.19%"},{"Ticker":"PCLN","EffectiveDate":"2015-12-16","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.64%","FiveDayReturnAfter":"-3.55%","FiveDayReturnBefore":"1.5%"},{"Ticker":"PCLN","EffectiveDate":"2015-12-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.64%","FiveDayReturnAfter":"-3.55%","FiveDayReturnBefore":"1.5%"},{"Ticker":"PCLN","EffectiveDate":"2015-12-10","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"0.88%","FiveDayReturnAfter":"2.84%","FiveDayReturnBefore":"1.52%"},{"Ticker":"PCLN","EffectiveDate":"2015-12-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.88%","FiveDayReturnAfter":"2.84%","FiveDayReturnBefore":"1.52%"},{"Ticker":"PCLN","EffectiveDate":"2015-11-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.24%","FiveDayReturnAfter":"-3.13%","FiveDayReturnBefore":"-2.25%"},{"Ticker":"PCLN","EffectiveDate":"2015-11-20","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-0.24%","FiveDayReturnAfter":"-3.13%","FiveDayReturnBefore":"-2.25%"},{"Ticker":"PCLN","EffectiveDate":"2015-11-20","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.24%","FiveDayReturnAfter":"-3.13%","FiveDayReturnBefore":"-2.25%"},{"Ticker":"PCLN","EffectiveDate":"2015-11-09","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades PCLN to Hold.","DailyReturn":"-9.56%","FiveDayReturnAfter":"-11.08%","FiveDayReturnBefore":"-0.29%"},{"Ticker":"PCLN","EffectiveDate":"2015-11-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.87%","FiveDayReturnAfter":"-10.71%","FiveDayReturnBefore":"2.56%"},{"Ticker":"PCLN","EffectiveDate":"2015-11-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.87%","FiveDayReturnAfter":"-10.71%","FiveDayReturnBefore":"2.56%"},{"Ticker":"PCLN","EffectiveDate":"2015-11-05","Type":"RatingNeutral","Title":"Deutsche Bank downgrades PCLN to Hold from Buy.","DailyReturn":"-0.47%","FiveDayReturnAfter":"-10%","FiveDayReturnBefore":"4.52%"},{"Ticker":"PCLN","EffectiveDate":"2015-11-04","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"0.31%","FiveDayReturnAfter":"-10.14%","FiveDayReturnBefore":"4.29%"},{"Ticker":"PCLN","EffectiveDate":"2015-11-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.31%","FiveDayReturnAfter":"-10.14%","FiveDayReturnBefore":"4.29%"},{"Ticker":"PCLN","EffectiveDate":"2015-09-09","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.28%","FiveDayReturnAfter":"2.95%","FiveDayReturnBefore":"2.51%"},{"Ticker":"PCLN","EffectiveDate":"2015-09-09","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.28%","FiveDayReturnAfter":"2.95%","FiveDayReturnBefore":"2.51%"},{"Ticker":"PCLN","EffectiveDate":"2015-09-04","Type":"RatingNeutral","Title":"Redburn Partners initiates coverage on PCLN to Buy.","DailyReturn":"0.39%","FiveDayReturnAfter":"3.95%","FiveDayReturnBefore":"-0.93%"},{"Ticker":"PCLN","EffectiveDate":"2015-08-05","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"5.23%","FiveDayReturnAfter":"1.84%","FiveDayReturnBefore":"6.09%"},{"Ticker":"PCLN","EffectiveDate":"2015-08-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"5.23%","FiveDayReturnAfter":"1.84%","FiveDayReturnBefore":"6.09%"},{"Ticker":"PCLN","EffectiveDate":"2015-07-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.4%","FiveDayReturnAfter":"-1.18%","FiveDayReturnBefore":"5.53%"},{"Ticker":"PCLN","EffectiveDate":"2015-07-23","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"-0.4%","FiveDayReturnAfter":"-1.18%","FiveDayReturnBefore":"5.53%"},{"Ticker":"PCLN","EffectiveDate":"2015-06-22","Type":"RatingNeutral","Title":"Deutsche Bank downgrades PCLN to Hold from Buy. Target Price is $1325; previously $1425.","DailyReturn":"-0.69%","FiveDayReturnAfter":"-1.52%","FiveDayReturnBefore":"-1.34%"},{"Ticker":"PCLN","EffectiveDate":"2015-06-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.32%","FiveDayReturnAfter":"-2.13%","FiveDayReturnBefore":"-0.67%"},{"Ticker":"PCLN","EffectiveDate":"2015-06-19","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-1.32%","FiveDayReturnAfter":"-2.13%","FiveDayReturnBefore":"-0.67%"},{"Ticker":"PCLN","EffectiveDate":"2015-06-19","Type":"Item_1.02","Title":"Termination of a Material Definitive Agreement\r\n","DailyReturn":"-1.32%","FiveDayReturnAfter":"-2.13%","FiveDayReturnBefore":"-0.67%"},{"Ticker":"PCLN","EffectiveDate":"2015-06-19","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"-1.32%","FiveDayReturnAfter":"-2.13%","FiveDayReturnBefore":"-0.67%"},{"Ticker":"PCLN","EffectiveDate":"2015-06-04","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-0.66%","FiveDayReturnAfter":"-1.16%","FiveDayReturnBefore":"-0.33%"},{"Ticker":"PCLN","EffectiveDate":"2015-06-03","Type":"RatingNeutral","Title":"Barclays initiates coverage on PCLN to Equal-Weight. Target Price is $1200.","DailyReturn":"-0.19%","FiveDayReturnAfter":"-2.77%","FiveDayReturnBefore":"0.02%"},{"Ticker":"PCLN","EffectiveDate":"2015-05-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.05%","FiveDayReturnAfter":"-3.52%","FiveDayReturnBefore":"0.8%"},{"Ticker":"PCLN","EffectiveDate":"2015-05-26","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"-1.05%","FiveDayReturnAfter":"-3.52%","FiveDayReturnBefore":"0.8%"},{"Ticker":"PCLN","EffectiveDate":"2015-05-19","Type":"RatingNeutral","Title":"Guggenheim initiates coverage on PCLN to Neutral.","DailyReturn":"-0.26%","FiveDayReturnAfter":"-1.74%","FiveDayReturnBefore":"2.53%"},{"Ticker":"PCLN","EffectiveDate":"2015-05-07","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-4%","FiveDayReturnAfter":"-7.07%","FiveDayReturnBefore":"1.24%"},{"Ticker":"PCLN","EffectiveDate":"2015-05-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-4%","FiveDayReturnAfter":"-7.07%","FiveDayReturnBefore":"1.24%"},{"Ticker":"PCLN","EffectiveDate":"2015-04-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.23%","FiveDayReturnAfter":"5.05%","FiveDayReturnBefore":"-0.69%"},{"Ticker":"PCLN","EffectiveDate":"2015-04-21","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"0.23%","FiveDayReturnAfter":"5.05%","FiveDayReturnBefore":"-0.69%"},{"Ticker":"PCLN","EffectiveDate":"2015-04-21","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.23%","FiveDayReturnAfter":"5.05%","FiveDayReturnBefore":"-0.69%"},{"Ticker":"PCLN","EffectiveDate":"2015-04-06","Type":"RatingNeutral","Title":"Argus Research initiates coverage on PCLN to Buy. Target Price is $1480.","DailyReturn":"2.11%","FiveDayReturnAfter":"2.47%","FiveDayReturnBefore":"1.74%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-31","Type":"RatingUpgrade","Title":"Stifel Nicolaus upgrades PCLN to Buy from Hold. Target Price is $1400.","DailyReturn":"1.24%","FiveDayReturnAfter":"3.01%","FiveDayReturnBefore":"-2.68%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-18","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $1352; previously $1375.","DailyReturn":"2.43%","FiveDayReturnAfter":"1.39%","FiveDayReturnBefore":"-3.2%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.43%","FiveDayReturnAfter":"1.39%","FiveDayReturnBefore":"-3.2%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-18","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"2.43%","FiveDayReturnAfter":"1.39%","FiveDayReturnBefore":"-3.2%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-13","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"-2.42%","FiveDayReturnAfter":"-0.87%","FiveDayReturnBefore":"-3.74%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-13","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-2.42%","FiveDayReturnAfter":"-0.87%","FiveDayReturnBefore":"-3.74%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.42%","FiveDayReturnAfter":"-0.87%","FiveDayReturnBefore":"-3.74%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-10","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-2.12%","FiveDayReturnAfter":"-4.93%","FiveDayReturnBefore":"-2.62%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-10","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"-2.12%","FiveDayReturnAfter":"-4.93%","FiveDayReturnBefore":"-2.62%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.12%","FiveDayReturnAfter":"-4.93%","FiveDayReturnBefore":"-2.62%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-04","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.31%","FiveDayReturnAfter":"-4.18%","FiveDayReturnBefore":"1.8%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.31%","FiveDayReturnAfter":"-4.18%","FiveDayReturnBefore":"1.8%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-03","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"-0.58%","FiveDayReturnAfter":"-2.62%","FiveDayReturnBefore":"3.4%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.58%","FiveDayReturnAfter":"-2.62%","FiveDayReturnBefore":"3.4%"},{"Ticker":"PCLN","EffectiveDate":"2015-03-03","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-0.58%","FiveDayReturnAfter":"-2.62%","FiveDayReturnBefore":"3.4%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"Morgan Stanley initiates coverage on PCLN to Equal-Weight. Target Price is $1300.","DailyReturn":"-0.76%","FiveDayReturnAfter":"-2.03%","FiveDayReturnBefore":"10.78%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.54%","FiveDayReturnAfter":"1.8%","FiveDayReturnBefore":"8.44%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"2.54%","FiveDayReturnAfter":"1.8%","FiveDayReturnBefore":"8.44%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.01%","FiveDayReturnAfter":"3.4%","FiveDayReturnBefore":"9.02%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.01%","FiveDayReturnAfter":"3.4%","FiveDayReturnBefore":"9.02%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-24","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"1.01%","FiveDayReturnAfter":"3.4%","FiveDayReturnBefore":"9.02%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-24","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"1.01%","FiveDayReturnAfter":"3.4%","FiveDayReturnBefore":"9.02%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-20","Type":"RatingNeutral","Title":"Ascendiant Capital maintains PCLN from Buy. Target Price is $1400; previously $1500.","DailyReturn":"-0.14%","FiveDayReturnAfter":"1.88%","FiveDayReturnBefore":"13.89%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-20","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $1425; previously $1375.","DailyReturn":"-0.14%","FiveDayReturnAfter":"1.88%","FiveDayReturnBefore":"13.89%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-20","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Market Outperform. Target Price is $1375; previously $1230.","DailyReturn":"-0.14%","FiveDayReturnAfter":"1.88%","FiveDayReturnBefore":"13.89%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-19","Type":"RatingNeutral","Title":"RBC Capital maintains PCLN to Outperform. Target Price is $1450; previously $1300.","DailyReturn":"8.46%","FiveDayReturnAfter":"10.78%","FiveDayReturnBefore":"5.99%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"8.46%","FiveDayReturnAfter":"10.78%","FiveDayReturnBefore":"5.99%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-19","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"8.46%","FiveDayReturnAfter":"10.78%","FiveDayReturnBefore":"5.99%"},{"Ticker":"PCLN","EffectiveDate":"2015-02-18","Type":"RatingNeutral","Title":"JMP Securities maintains PCLN to Market Outperform. Target Price is $1230; previously $1300.","DailyReturn":"0.17%","FiveDayReturnAfter":"8.44%","FiveDayReturnBefore":"8.15%"},{"Ticker":"PCLN","EffectiveDate":"2015-01-23","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $1375; previously $1410.","DailyReturn":"-1.11%","FiveDayReturnAfter":"-3.38%","FiveDayReturnBefore":"1.34%"},{"Ticker":"PCLN","EffectiveDate":"2015-01-08","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades PCLN from Buy.","DailyReturn":"1.24%","FiveDayReturnAfter":"-3.22%","FiveDayReturnBefore":"-7.13%"},{"Ticker":"PCLN","EffectiveDate":"2014-12-16","Type":"RatingNeutral","Title":"Bank of America maintains PCLN to Buy. Target Price is $1310; previously $1265.","DailyReturn":"-3.04%","FiveDayReturnAfter":"6.35%","FiveDayReturnBefore":"-5.15%"},{"Ticker":"PCLN","EffectiveDate":"2014-12-15","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"-2.29%","FiveDayReturnAfter":"0.49%","FiveDayReturnBefore":"-2.85%"},{"Ticker":"PCLN","EffectiveDate":"2014-12-02","Type":"RatingNeutral","Title":"FBR Capital downgrades PCLN to Market Perform from Outperform. Target Price is $1225.","DailyReturn":"-1.2%","FiveDayReturnAfter":"-1.53%","FiveDayReturnBefore":"0.15%"},{"Ticker":"PCLN","EffectiveDate":"2014-11-25","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"1.64%","FiveDayReturnAfter":"-1.8%","FiveDayReturnBefore":"-0.53%"},{"Ticker":"PCLN","EffectiveDate":"2014-11-24","Type":"RatingNeutral","Title":"Credit Suisse assumes PCLN to Outperform. Target Price is $1450.","DailyReturn":"0.75%","FiveDayReturnAfter":"0.15%","FiveDayReturnBefore":"-1.84%"},{"Ticker":"PCLN","EffectiveDate":"2014-11-14","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $1350; previously $1500.","DailyReturn":"0.42%","FiveDayReturnAfter":"-1.21%","FiveDayReturnBefore":"6.2%"},{"Ticker":"PCLN","EffectiveDate":"2014-11-05","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $1410; previously $1460.","DailyReturn":"-0.21%","FiveDayReturnAfter":"6.15%","FiveDayReturnBefore":"-5.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-11-05","Type":"RatingNeutral","Title":"FBR Capital maintains PCLN to Outperform. Target Price is $1225; previously $1500.","DailyReturn":"-0.21%","FiveDayReturnAfter":"6.15%","FiveDayReturnBefore":"-5.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-11-05","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $1500; previously $1545.","DailyReturn":"-0.21%","FiveDayReturnAfter":"6.15%","FiveDayReturnBefore":"-5.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-11-05","Type":"RatingNeutral","Title":"JMP Securities maintains PCLN to Market Outperform. Target Price is $1300; previously $1450.","DailyReturn":"-0.21%","FiveDayReturnAfter":"6.15%","FiveDayReturnBefore":"-5.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-11-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-8.41%","FiveDayReturnAfter":"-6.77%","FiveDayReturnBefore":"5.51%"},{"Ticker":"PCLN","EffectiveDate":"2014-11-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-8.41%","FiveDayReturnAfter":"-6.77%","FiveDayReturnBefore":"5.51%"},{"Ticker":"PCLN","EffectiveDate":"2014-11-04","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $1450; previously $1555.","DailyReturn":"-8.41%","FiveDayReturnAfter":"-6.77%","FiveDayReturnBefore":"5.51%"},{"Ticker":"PCLN","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $1460; previously $1520.","DailyReturn":"0.2%","FiveDayReturnAfter":"-4.36%","FiveDayReturnBefore":"2.63%"},{"Ticker":"PCLN","EffectiveDate":"2014-10-15","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $1550; previously $1600.","DailyReturn":"0.79%","FiveDayReturnAfter":"7.56%","FiveDayReturnBefore":"-5.43%"},{"Ticker":"PCLN","EffectiveDate":"2014-10-10","Type":"RatingNeutral","Title":"Evercore Partners downgrades PCLN to Hold from Equal-Weight. Target Price is $1250; previously $1350.","DailyReturn":"-3.49%","FiveDayReturnAfter":"-2.66%","FiveDayReturnBefore":"-3.36%"},{"Ticker":"PCLN","EffectiveDate":"2014-10-10","Type":"RatingNeutral","Title":"Susquehanna maintains PCLN to Positive. Target Price is $1475; previously $1500.","DailyReturn":"-3.49%","FiveDayReturnAfter":"-2.66%","FiveDayReturnBefore":"-3.36%"},{"Ticker":"PCLN","EffectiveDate":"2014-09-23","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"0.04%","FiveDayReturnAfter":"-0.4%","FiveDayReturnBefore":"1.05%"},{"Ticker":"PCLN","EffectiveDate":"2014-09-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.04%","FiveDayReturnAfter":"-0.4%","FiveDayReturnBefore":"1.05%"},{"Ticker":"PCLN","EffectiveDate":"2014-09-23","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"0.04%","FiveDayReturnAfter":"-0.4%","FiveDayReturnBefore":"1.05%"},{"Ticker":"PCLN","EffectiveDate":"2014-09-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.67%","FiveDayReturnAfter":"1.05%","FiveDayReturnBefore":"-3.84%"},{"Ticker":"PCLN","EffectiveDate":"2014-09-16","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"1.67%","FiveDayReturnAfter":"1.05%","FiveDayReturnBefore":"-3.84%"},{"Ticker":"PCLN","EffectiveDate":"2014-09-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.67%","FiveDayReturnAfter":"1.05%","FiveDayReturnBefore":"-3.84%"},{"Ticker":"PCLN","EffectiveDate":"2014-09-16","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"1.67%","FiveDayReturnAfter":"1.05%","FiveDayReturnBefore":"-3.84%"},{"Ticker":"PCLN","EffectiveDate":"2014-09-05","Type":"RatingNeutral","Title":"Evercore Partners downgrades PCLN to Equal-weight from Overweight. Target Price is $1350; previously $1450.","DailyReturn":"-2.1%","FiveDayReturnAfter":"-3.66%","FiveDayReturnBefore":"-3.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-14","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"-0.69%","FiveDayReturnAfter":"-1.58%","FiveDayReturnBefore":"1.02%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-14","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":"-0.69%","FiveDayReturnAfter":"-1.58%","FiveDayReturnBefore":"1.02%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-14","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.69%","FiveDayReturnAfter":"-1.58%","FiveDayReturnBefore":"1.02%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-14","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.69%","FiveDayReturnAfter":"-1.58%","FiveDayReturnBefore":"1.02%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-14","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-0.69%","FiveDayReturnAfter":"-1.58%","FiveDayReturnBefore":"1.02%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-14","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"-0.69%","FiveDayReturnAfter":"-1.58%","FiveDayReturnBefore":"1.02%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-13","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"-0.04%","FiveDayReturnAfter":"-1.75%","FiveDayReturnBefore":"1.02%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-13","Type":"RatingNeutral","Title":"Stifel Nicolaus initiates coverage on PCLN to Buy. Target Price is $1600.","DailyReturn":"-0.04%","FiveDayReturnAfter":"-1.75%","FiveDayReturnBefore":"1.02%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.04%","FiveDayReturnAfter":"-1.75%","FiveDayReturnBefore":"1.02%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-12","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $1545; previously $1500.","DailyReturn":"-1.13%","FiveDayReturnAfter":"-2.56%","FiveDayReturnBefore":"0.71%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-12","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $1520; previously $1300.","DailyReturn":"-1.13%","FiveDayReturnAfter":"-2.56%","FiveDayReturnBefore":"0.71%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-12","Type":"RatingNeutral","Title":"Pacific Crest maintains PCLN to Outperform. Target Price is $1565; previously $1475.","DailyReturn":"-1.13%","FiveDayReturnAfter":"-2.56%","FiveDayReturnBefore":"0.71%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-12","Type":"RatingNeutral","Title":"Macquarie maintains PCLN to Outperform. Target Price is $1595; previously $1500.","DailyReturn":"-1.13%","FiveDayReturnAfter":"-2.56%","FiveDayReturnBefore":"0.71%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-12","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $1600; previously $1500.","DailyReturn":"-1.13%","FiveDayReturnAfter":"-2.56%","FiveDayReturnBefore":"0.71%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-11","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.16%","FiveDayReturnAfter":"-0.89%","FiveDayReturnBefore":"2.82%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.16%","FiveDayReturnAfter":"-0.89%","FiveDayReturnBefore":"2.82%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.05%","FiveDayReturnAfter":"1.02%","FiveDayReturnBefore":"2.73%"},{"Ticker":"PCLN","EffectiveDate":"2014-08-06","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.05%","FiveDayReturnAfter":"1.02%","FiveDayReturnBefore":"2.73%"},{"Ticker":"PCLN","EffectiveDate":"2014-07-24","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":"-0.15%","FiveDayReturnAfter":"1.38%","FiveDayReturnBefore":"1.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-07-24","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.15%","FiveDayReturnAfter":"1.38%","FiveDayReturnBefore":"1.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-07-24","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":"-0.15%","FiveDayReturnAfter":"1.38%","FiveDayReturnBefore":"1.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-07-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.15%","FiveDayReturnAfter":"1.38%","FiveDayReturnBefore":"1.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-07-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.15%","FiveDayReturnAfter":"1.38%","FiveDayReturnBefore":"1.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-07-18","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"0.94%","FiveDayReturnAfter":"2.9%","FiveDayReturnBefore":"-1.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-07-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.94%","FiveDayReturnAfter":"2.9%","FiveDayReturnBefore":"-1.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-06-30","Type":"RatingNeutral","Title":"Oppenheimer initiates coverage on PCLN to Outperform. Target Price is $1450.","DailyReturn":"-0.2%","FiveDayReturnAfter":"3.81%","FiveDayReturnBefore":"0.19%"},{"Ticker":"PCLN","EffectiveDate":"2014-06-27","Type":"RatingNeutral","Title":"Buckingham Research initiates coverage on PCLN to Neutral. Target Price is $1400.","DailyReturn":"-1%","FiveDayReturnAfter":"2.06%","FiveDayReturnBefore":"0.89%"},{"Ticker":"PCLN","EffectiveDate":"2014-06-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.81%","FiveDayReturnAfter":"-2.58%","FiveDayReturnBefore":"0.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-06-12","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-1.81%","FiveDayReturnAfter":"-2.58%","FiveDayReturnBefore":"0.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-06-12","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-1.81%","FiveDayReturnAfter":"-2.58%","FiveDayReturnBefore":"0.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-06-12","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"-1.81%","FiveDayReturnAfter":"-2.58%","FiveDayReturnBefore":"0.22%"},{"Ticker":"PCLN","EffectiveDate":"2014-06-05","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.15%","FiveDayReturnAfter":"0.22%","FiveDayReturnBefore":"-1.91%"},{"Ticker":"PCLN","EffectiveDate":"2014-05-09","Type":"RatingNeutral","Title":"UBS maintains PCLN to Buy. Target Price is $1500; previously $1480.","DailyReturn":"2.51%","FiveDayReturnAfter":"2.51%","FiveDayReturnBefore":"-6.34%"},{"Ticker":"PCLN","EffectiveDate":"2014-05-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.09%","FiveDayReturnAfter":"1.23%","FiveDayReturnBefore":"-2.27%"},{"Ticker":"PCLN","EffectiveDate":"2014-05-08","Type":"RatingUpgrade","Title":"Raymond James upgrades PCLN to Strong Buy from Outperform.","DailyReturn":"-2.09%","FiveDayReturnAfter":"1.23%","FiveDayReturnBefore":"-2.27%"},{"Ticker":"PCLN","EffectiveDate":"2014-05-08","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.09%","FiveDayReturnAfter":"1.23%","FiveDayReturnBefore":"-2.27%"},{"Ticker":"PCLN","EffectiveDate":"2014-04-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"4.99%","FiveDayReturnAfter":"-1.87%","FiveDayReturnBefore":"-2.97%"},{"Ticker":"PCLN","EffectiveDate":"2014-04-01","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"4.99%","FiveDayReturnAfter":"-1.87%","FiveDayReturnBefore":"-2.97%"},{"Ticker":"PCLN","EffectiveDate":"2014-03-04","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"2.24%","FiveDayReturnAfter":"0.38%","FiveDayReturnBefore":"1.85%"},{"Ticker":"PCLN","EffectiveDate":"2014-03-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.24%","FiveDayReturnAfter":"0.38%","FiveDayReturnBefore":"1.85%"},{"Ticker":"PCLN","EffectiveDate":"2014-02-21","Type":"RatingNeutral","Title":"Bank of America maintains PCLN to Buy. Target Price is $1400; previously $1300.","DailyReturn":"2.54%","FiveDayReturnAfter":"5.66%","FiveDayReturnBefore":"2.87%"},{"Ticker":"PCLN","EffectiveDate":"2014-02-21","Type":"RatingNeutral","Title":"Macquarie maintains PCLN to Outperform. Target Price is $1500; previously $1380.","DailyReturn":"2.54%","FiveDayReturnAfter":"5.66%","FiveDayReturnBefore":"2.87%"},{"Ticker":"PCLN","EffectiveDate":"2014-02-21","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $1450; previously $1320.","DailyReturn":"2.54%","FiveDayReturnAfter":"5.66%","FiveDayReturnBefore":"2.87%"},{"Ticker":"PCLN","EffectiveDate":"2014-02-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.72%","FiveDayReturnAfter":"6.32%","FiveDayReturnBefore":"4.81%"},{"Ticker":"PCLN","EffectiveDate":"2014-02-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.72%","FiveDayReturnAfter":"6.32%","FiveDayReturnBefore":"4.81%"},{"Ticker":"PCLN","EffectiveDate":"2014-02-20","Type":"RatingNeutral","Title":"Oracle Investment Research initiates coverage on PCLN to Strong Buy. Target Price is $1400.","DailyReturn":"0.72%","FiveDayReturnAfter":"6.32%","FiveDayReturnBefore":"4.81%"},{"Ticker":"PCLN","EffectiveDate":"2014-02-19","Type":"RatingNeutral","Title":"Monness Crespi Hardt maintains PCLN to Buy. Target Price is $1500; previously $1250.","DailyReturn":"-2.14%","FiveDayReturnAfter":"3.9%","FiveDayReturnBefore":"7.48%"},{"Ticker":"PCLN","EffectiveDate":"2014-02-13","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $1450; previously $1275.","DailyReturn":"2.36%","FiveDayReturnAfter":"2.87%","FiveDayReturnBefore":"10.35%"},{"Ticker":"PCLN","EffectiveDate":"2014-01-07","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $1320; previously $1210.","DailyReturn":"2.06%","FiveDayReturnAfter":"0.01%","FiveDayReturnBefore":"-2.66%"},{"Ticker":"PCLN","EffectiveDate":"2013-12-05","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"-0.61%","FiveDayReturnAfter":"-0.3%","FiveDayReturnBefore":"0.31%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-26","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"1.62%","FiveDayReturnAfter":"1.48%","FiveDayReturnBefore":"2.73%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-20","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades PCLN to Conviction Buy from Buy. Target Price is $1500; previously $1260.","DailyReturn":"2.56%","FiveDayReturnAfter":"5.18%","FiveDayReturnBefore":"1.7%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-08","Type":"RatingNeutral","Title":"Benchmark maintains PCLN to Buy. Target Price is $1200; previously $1100.","DailyReturn":"4.91%","FiveDayReturnAfter":"10.61%","FiveDayReturnBefore":"-2.98%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-08","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains PCLN to Buy. Target Price is $1250; previously $1200.","DailyReturn":"4.91%","FiveDayReturnAfter":"10.61%","FiveDayReturnBefore":"-2.98%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-08","Type":"RatingUpgrade","Title":"Monness, Crespi, Hardt upgrades PCLN to Buy from Neutral.","DailyReturn":"4.91%","FiveDayReturnAfter":"10.61%","FiveDayReturnBefore":"-2.98%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-08","Type":"RatingUpgrade","Title":"Monness Crespi Hardt upgrades PCLN to Buy from Neutral. Target Price is $1250.","DailyReturn":"4.91%","FiveDayReturnAfter":"10.61%","FiveDayReturnBefore":"-2.98%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-07","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-3.32%","FiveDayReturnAfter":"6.06%","FiveDayReturnBefore":"-0.98%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-3.32%","FiveDayReturnAfter":"6.06%","FiveDayReturnBefore":"-0.98%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-07","Type":"EarningsRevenueBeat","Title":"After market close, PCLN reports 2013 Q3's earning $17.33 per share and revenue $2269MM. This beats analyst's estimated EPS $16.21, beats estimated revenue $2210MM.","DailyReturn":"-3.32%","FiveDayReturnAfter":"6.06%","FiveDayReturnBefore":"-0.98%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-05","Type":"RatingNeutral","Title":"Bank of America maintains PCLN to Buy. Target Price is $1220; previously $1060.","DailyReturn":"1.08%","FiveDayReturnAfter":"2.39%","FiveDayReturnBefore":"0.97%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-05","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $1150.","DailyReturn":"1.08%","FiveDayReturnAfter":"2.39%","FiveDayReturnBefore":"0.97%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.71%","FiveDayReturnAfter":"1.94%","FiveDayReturnBefore":"-1.72%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.71%","FiveDayReturnAfter":"1.94%","FiveDayReturnBefore":"-1.72%"},{"Ticker":"PCLN","EffectiveDate":"2013-11-04","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":"1.71%","FiveDayReturnAfter":"1.94%","FiveDayReturnBefore":"-1.72%"},{"Ticker":"PCLN","EffectiveDate":"2013-10-23","Type":"RatingNeutral","Title":"FBR Capital initiates coverage on PCLN to Outperform. Target Price is $1250.","DailyReturn":"-0.89%","FiveDayReturnAfter":"-0.56%","FiveDayReturnBefore":"5.16%"},{"Ticker":"PCLN","EffectiveDate":"2013-10-22","Type":"RatingNeutral","Title":"Credit Suisse assumes PCLN to Outperform. Target Price is $1250.","DailyReturn":"-1.05%","FiveDayReturnAfter":"-2.5%","FiveDayReturnBefore":"6.6%"},{"Ticker":"PCLN","EffectiveDate":"2013-10-21","Type":"RatingNeutral","Title":"Susquehanna maintains PCLN to Positive. Target Price is $1200; previously $1135.","DailyReturn":"3.7%","FiveDayReturnAfter":"2.13%","FiveDayReturnBefore":"3.65%"},{"Ticker":"PCLN","EffectiveDate":"2013-09-12","Type":"RatingNeutral","Title":"Janney Capital initiates coverage on PCLN to Neutral. Target Price is $925.","DailyReturn":"-1.19%","FiveDayReturnAfter":"1.36%","FiveDayReturnBefore":"3.01%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $1130; previously $1040.","DailyReturn":"3.87%","FiveDayReturnAfter":"0.53%","FiveDayReturnBefore":"3.19%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $1050; previously $900.","DailyReturn":"3.87%","FiveDayReturnAfter":"0.53%","FiveDayReturnBefore":"3.19%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"3.87%","FiveDayReturnAfter":"0.53%","FiveDayReturnBefore":"3.19%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Benchmark maintains PCLN to Buy. Target Price is $1100; previously $800.","DailyReturn":"3.87%","FiveDayReturnAfter":"0.53%","FiveDayReturnBefore":"3.19%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $1150; previously $1010.","DailyReturn":"3.87%","FiveDayReturnAfter":"0.53%","FiveDayReturnBefore":"3.19%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Bank of America maintains PCLN to Buy. Target Price is $1060; previously $940.","DailyReturn":"3.87%","FiveDayReturnAfter":"0.53%","FiveDayReturnBefore":"3.19%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $1130; previously $1005.","DailyReturn":"3.87%","FiveDayReturnAfter":"0.53%","FiveDayReturnBefore":"3.19%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"PiperJaffray maintains PCLN to Overweight. Target Price is $1100; previously $1034.","DailyReturn":"3.87%","FiveDayReturnAfter":"0.53%","FiveDayReturnBefore":"3.19%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $1120; previously $980.","DailyReturn":"3.87%","FiveDayReturnAfter":"0.53%","FiveDayReturnBefore":"3.19%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Buy. Target Price is $1200; previously $985.","DailyReturn":"3.87%","FiveDayReturnAfter":"0.53%","FiveDayReturnBefore":"3.19%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains PCLN to Buy. Target Price is $1200; previously $1025.","DailyReturn":"3.87%","FiveDayReturnAfter":"0.53%","FiveDayReturnBefore":"3.19%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-08","Type":"EarningsRevenueBeat","Title":"After market close, PCLN reports 2013 Q2's earning $9.7 per share and revenue $1680MM. This beats analyst's estimated EPS $9.38, beats estimated revenue $1660MM.","DailyReturn":"0.66%","FiveDayReturnAfter":"1.33%","FiveDayReturnBefore":"5.75%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-08","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.66%","FiveDayReturnAfter":"1.33%","FiveDayReturnBefore":"5.75%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.66%","FiveDayReturnAfter":"1.33%","FiveDayReturnBefore":"5.75%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.73%","FiveDayReturnAfter":"3.12%","FiveDayReturnBefore":"4.45%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-06","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":"0.73%","FiveDayReturnAfter":"3.12%","FiveDayReturnBefore":"4.45%"},{"Ticker":"PCLN","EffectiveDate":"2013-08-01","Type":"RatingNeutral","Title":"Bank of America maintains PCLN to Buy. Target Price is $940; previously $925.","DailyReturn":"3.27%","FiveDayReturnAfter":"5.75%","FiveDayReturnBefore":"-2.07%"},{"Ticker":"PCLN","EffectiveDate":"2013-07-30","Type":"RatingNeutral","Title":"PiperJaffray maintains PCLN to Overweight. Target Price is $1034; previously $850.","DailyReturn":"-0.14%","FiveDayReturnAfter":"4.45%","FiveDayReturnBefore":"-1.38%"},{"Ticker":"PCLN","EffectiveDate":"2013-07-24","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains PCLN to Buy. Target Price is $1025; previously $860.","DailyReturn":"-0.19%","FiveDayReturnAfter":"-1%","FiveDayReturnBefore":"-0.69%"},{"Ticker":"PCLN","EffectiveDate":"2013-07-10","Type":"RatingNeutral","Title":"Susquehanna initiates coverage on PCLN to Positive. Target Price is $1080.","DailyReturn":"-0.52%","FiveDayReturnAfter":"0.55%","FiveDayReturnBefore":"6.48%"},{"Ticker":"PCLN","EffectiveDate":"2013-07-08","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades PCLN to Overweight from Equal-Weight. Target Price is $1010; previously $760.","DailyReturn":"3.91%","FiveDayReturnAfter":"7.35%","FiveDayReturnBefore":"3.9%"},{"Ticker":"PCLN","EffectiveDate":"2013-06-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.3%","FiveDayReturnAfter":"1.54%","FiveDayReturnBefore":"0.4%"},{"Ticker":"PCLN","EffectiveDate":"2013-06-06","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.3%","FiveDayReturnAfter":"1.54%","FiveDayReturnBefore":"0.4%"},{"Ticker":"PCLN","EffectiveDate":"2013-06-06","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"1.3%","FiveDayReturnAfter":"1.54%","FiveDayReturnBefore":"0.4%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.92%","FiveDayReturnAfter":"0.4%","FiveDayReturnBefore":"-4.16%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-30","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"1.92%","FiveDayReturnAfter":"0.4%","FiveDayReturnBefore":"-4.16%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":"-1.49%","FiveDayReturnAfter":"-0.7%","FiveDayReturnBefore":"-4.63%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.49%","FiveDayReturnAfter":"-0.7%","FiveDayReturnBefore":"-4.63%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-1.49%","FiveDayReturnAfter":"-0.7%","FiveDayReturnBefore":"-4.63%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"-1.49%","FiveDayReturnAfter":"-0.7%","FiveDayReturnBefore":"-4.63%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"-1.49%","FiveDayReturnAfter":"-0.7%","FiveDayReturnBefore":"-4.63%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"RatingNeutral","Title":"Lazard maintains PCLN to Buy. Target Price is $950; previously $859.","DailyReturn":"-1.49%","FiveDayReturnAfter":"-0.7%","FiveDayReturnBefore":"-4.63%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.49%","FiveDayReturnAfter":"-0.7%","FiveDayReturnBefore":"-4.63%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.96%","FiveDayReturnAfter":"-4.63%","FiveDayReturnBefore":"8.03%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-21","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":"-1.96%","FiveDayReturnAfter":"-4.63%","FiveDayReturnBefore":"8.03%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-21","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-1.96%","FiveDayReturnAfter":"-4.63%","FiveDayReturnBefore":"8.03%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-20","Type":"RatingUpgrade","Title":"Deutsche Bank upgrades PCLN to Buy from Hold. Target Price is $900; previously $715.","DailyReturn":"3.54%","FiveDayReturnAfter":"-1.55%","FiveDayReturnBefore":"6.11%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-09","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.3%","FiveDayReturnAfter":"9.15%","FiveDayReturnBefore":"5.76%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-09","Type":"EarningsRevenueBeat","Title":"After market close, PCLN reports 2013 Q1's earning $5.76 per share and revenue $1300MM. This beats analyst's estimated EPS $5.27, beats estimated revenue $1280MM.","DailyReturn":"0.3%","FiveDayReturnAfter":"9.15%","FiveDayReturnBefore":"5.76%"},{"Ticker":"PCLN","EffectiveDate":"2013-05-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.3%","FiveDayReturnAfter":"9.15%","FiveDayReturnBefore":"5.76%"},{"Ticker":"PCLN","EffectiveDate":"2013-04-02","Type":"RatingNeutral","Title":"UBS initiates coverage on PCLN to Buy. Target Price is $825.","DailyReturn":"1.45%","FiveDayReturnAfter":"0.11%","FiveDayReturnBefore":"-0.3%"},{"Ticker":"PCLN","EffectiveDate":"2013-03-21","Type":"RatingNeutral","Title":"Evercore Partners assumes PCLN to Overweight. Target Price is $850.","DailyReturn":"-0.52%","FiveDayReturnAfter":"1.05%","FiveDayReturnBefore":"-3.98%"},{"Ticker":"PCLN","EffectiveDate":"2013-03-19","Type":"RatingNeutral","Title":"JMP Securities initiates coverage on PCLN to Market Outperform. Target Price is $850.","DailyReturn":"-1.81%","FiveDayReturnAfter":"-0.16%","FiveDayReturnBefore":"-3.97%"},{"Ticker":"PCLN","EffectiveDate":"2013-03-01","Type":"RatingUpgrade","Title":"Lazard upgrades PCLN to Buy from Neutral.","DailyReturn":"0.94%","FiveDayReturnAfter":"4.25%","FiveDayReturnBefore":"0.84%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $800; previously $750.","DailyReturn":"2.56%","FiveDayReturnAfter":"5.71%","FiveDayReturnBefore":"-3.61%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Ascendiant Capital maintains PCLN to Buy. Target Price is $875; previously $870.","DailyReturn":"2.56%","FiveDayReturnAfter":"5.71%","FiveDayReturnBefore":"-3.61%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $820; previously $780.","DailyReturn":"2.56%","FiveDayReturnAfter":"5.71%","FiveDayReturnBefore":"-3.61%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Buy. Target Price is $825; previously $770.","DailyReturn":"2.56%","FiveDayReturnAfter":"5.71%","FiveDayReturnBefore":"-3.61%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $895; previously $847.","DailyReturn":"2.56%","FiveDayReturnAfter":"5.71%","FiveDayReturnBefore":"-3.61%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $835; previously $740.","DailyReturn":"2.56%","FiveDayReturnAfter":"5.71%","FiveDayReturnBefore":"-3.61%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains PCLN to Buy. Target Price is $860; previously $760.","DailyReturn":"2.56%","FiveDayReturnAfter":"5.71%","FiveDayReturnBefore":"-3.61%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Hold. Target Price is $745; previously $710.","DailyReturn":"2.56%","FiveDayReturnAfter":"5.71%","FiveDayReturnBefore":"-3.61%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"PiperJaffray maintains PCLN to Overweight. Target Price is $800; previously $756.","DailyReturn":"2.56%","FiveDayReturnAfter":"5.71%","FiveDayReturnBefore":"-3.61%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-26","Type":"EarningBeat","Title":"After market close, PCLN reports 2012 Q4's earning $6.77 per share and revenue $1190MM. This beats analyst's estimated EPS $6.54, meets estimated revenue $1190MM.","DailyReturn":"1.03%","FiveDayReturnAfter":"6.13%","FiveDayReturnBefore":"-4.47%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-26","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"1.03%","FiveDayReturnAfter":"6.13%","FiveDayReturnBefore":"-4.47%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.03%","FiveDayReturnAfter":"6.13%","FiveDayReturnBefore":"-4.47%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-26","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.03%","FiveDayReturnAfter":"6.13%","FiveDayReturnBefore":"-4.47%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.03%","FiveDayReturnAfter":"6.13%","FiveDayReturnBefore":"-4.47%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.03%","FiveDayReturnAfter":"6.13%","FiveDayReturnBefore":"-4.47%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-22","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"0.2%","FiveDayReturnAfter":"0.84%","FiveDayReturnBefore":"-3%"},{"Ticker":"PCLN","EffectiveDate":"2013-02-22","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.2%","FiveDayReturnAfter":"0.84%","FiveDayReturnBefore":"-3%"},{"Ticker":"PCLN","EffectiveDate":"2013-01-31","Type":"RatingNeutral","Title":"Morgan Stanley downgrades PCLN to Equal-Weight from Overweight. Target Price is $730; previously $750.","DailyReturn":"-1.38%","FiveDayReturnAfter":"-0.14%","FiveDayReturnBefore":"3.33%"},{"Ticker":"PCLN","EffectiveDate":"2013-01-30","Type":"RatingNeutral","Title":"Ascendiant Capital initiates coverage on PCLN to Buy. Target Price is $870.","DailyReturn":"-0.74%","FiveDayReturnAfter":"-1.25%","FiveDayReturnBefore":"4.23%"},{"Ticker":"PCLN","EffectiveDate":"2013-01-29","Type":"RatingNeutral","Title":"Ascendiant initiates coverage on PCLN to Buy. Target Price is $870.","DailyReturn":"-0.66%","FiveDayReturnAfter":"-3.71%","FiveDayReturnBefore":"4.68%"},{"Ticker":"PCLN","EffectiveDate":"2013-01-25","Type":"RatingNeutral","Title":"Nomura maintains PCLN to Buy. Target Price is $820; previously $730.","DailyReturn":"5.77%","FiveDayReturnAfter":"0.86%","FiveDayReturnBefore":"1.73%"},{"Ticker":"PCLN","EffectiveDate":"2013-01-03","Type":"RatingUpgrade","Title":"Bank of America upgrades PCLN to Buy from Neutral. Target Price is $770; previously $690.","DailyReturn":"1.61%","FiveDayReturnAfter":"2.04%","FiveDayReturnBefore":"3.35%"},{"Ticker":"PCLN","EffectiveDate":"2013-01-03","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.61%","FiveDayReturnAfter":"2.04%","FiveDayReturnBefore":"3.35%"},{"Ticker":"PCLN","EffectiveDate":"2013-01-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.61%","FiveDayReturnAfter":"2.04%","FiveDayReturnBefore":"3.35%"},{"Ticker":"PCLN","EffectiveDate":"2012-12-12","Type":"RatingNeutral","Title":"Janney Capital initiates coverage on PCLN to Neutral. Target Price is $650.","DailyReturn":"0.24%","FiveDayReturnAfter":"1.51%","FiveDayReturnBefore":"-6.3%"},{"Ticker":"PCLN","EffectiveDate":"2012-12-10","Type":"RatingNeutral","Title":"Deutsche Bank downgrades PCLN to Hold from Buy. Target Price is $710; previously $800.","DailyReturn":"-5.02%","FiveDayReturnAfter":"-7.16%","FiveDayReturnBefore":"-0.61%"},{"Ticker":"PCLN","EffectiveDate":"2012-12-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-5.02%","FiveDayReturnAfter":"-7.16%","FiveDayReturnBefore":"-0.61%"},{"Ticker":"PCLN","EffectiveDate":"2012-12-10","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-5.02%","FiveDayReturnAfter":"-7.16%","FiveDayReturnBefore":"-0.61%"},{"Ticker":"PCLN","EffectiveDate":"2012-12-07","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.75%","FiveDayReturnAfter":"-7.99%","FiveDayReturnBefore":"-0.24%"},{"Ticker":"PCLN","EffectiveDate":"2012-11-21","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.62%","FiveDayReturnAfter":"3.47%","FiveDayReturnBefore":"0.83%"},{"Ticker":"PCLN","EffectiveDate":"2012-11-20","Type":"RatingNeutral","Title":"JG Capital initiates coverage on PCLN to Overweight. Target Price is $780.","DailyReturn":"1.61%","FiveDayReturnAfter":"1.78%","FiveDayReturnBefore":"-1.25%"},{"Ticker":"PCLN","EffectiveDate":"2012-11-08","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-1.06%","FiveDayReturnAfter":"-2.91%","FiveDayReturnBefore":"10.07%"},{"Ticker":"PCLN","EffectiveDate":"2012-11-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.06%","FiveDayReturnAfter":"-2.91%","FiveDayReturnBefore":"10.07%"},{"Ticker":"PCLN","EffectiveDate":"2012-11-02","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $800; previously $750.","DailyReturn":"8.29%","FiveDayReturnAfter":"6.88%","FiveDayReturnBefore":"2.95%"},{"Ticker":"PCLN","EffectiveDate":"2012-11-02","Type":"RatingUpgrade","Title":"Stifel Nicolaus upgrades PCLN to Buy from Hold. Target Price is $760.","DailyReturn":"8.29%","FiveDayReturnAfter":"6.88%","FiveDayReturnBefore":"2.95%"},{"Ticker":"PCLN","EffectiveDate":"2012-11-02","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $838; previously $806.","DailyReturn":"8.29%","FiveDayReturnAfter":"6.88%","FiveDayReturnBefore":"2.95%"},{"Ticker":"PCLN","EffectiveDate":"2012-11-02","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $780; previously $740.","DailyReturn":"8.29%","FiveDayReturnAfter":"6.88%","FiveDayReturnBefore":"2.95%"},{"Ticker":"PCLN","EffectiveDate":"2012-11-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.14%","FiveDayReturnAfter":"10.07%","FiveDayReturnBefore":"1.15%"},{"Ticker":"PCLN","EffectiveDate":"2012-11-01","Type":"EarningsRevenueBeat","Title":"After market close, PCLN reports 2012 Q3's earning $12.4 per share and revenue $1700MM. This beats analyst's estimated EPS $11.81, beats estimated revenue $1650MM.","DailyReturn":"2.14%","FiveDayReturnAfter":"10.07%","FiveDayReturnBefore":"1.15%"},{"Ticker":"PCLN","EffectiveDate":"2012-11-01","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"2.14%","FiveDayReturnAfter":"10.07%","FiveDayReturnBefore":"1.15%"},{"Ticker":"PCLN","EffectiveDate":"2012-11-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.14%","FiveDayReturnAfter":"10.07%","FiveDayReturnBefore":"1.15%"},{"Ticker":"PCLN","EffectiveDate":"2012-10-17","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $806; previously $727.","DailyReturn":"0.07%","FiveDayReturnAfter":"-4.92%","FiveDayReturnBefore":"-3.31%"},{"Ticker":"PCLN","EffectiveDate":"2012-10-10","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-2.5%","FiveDayReturnAfter":"-3.31%","FiveDayReturnBefore":"0.26%"},{"Ticker":"PCLN","EffectiveDate":"2012-10-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.5%","FiveDayReturnAfter":"-3.31%","FiveDayReturnBefore":"0.26%"},{"Ticker":"PCLN","EffectiveDate":"2012-09-21","Type":"RatingNeutral","Title":"Cantor Fitzgerald initiates coverage on PCLN to Buy. Target Price is $740.","DailyReturn":"0.37%","FiveDayReturnAfter":"-0.51%","FiveDayReturnBefore":"1.08%"},{"Ticker":"PCLN","EffectiveDate":"2012-09-07","Type":"RatingUpgrade","Title":"Nomura upgrades PCLN to Buy from Neutral. Target Price is $700; previously $740.","DailyReturn":"2.9%","FiveDayReturnAfter":"3.72%","FiveDayReturnBefore":"0.13%"},{"Ticker":"PCLN","EffectiveDate":"2012-09-04","Type":"RatingNeutral","Title":"Jefferies assumes PCLN to Buy. Target Price is $740; previously $695.","DailyReturn":"-1.27%","FiveDayReturnAfter":"0.61%","FiveDayReturnBefore":"1.9%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-17","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"0.33%","FiveDayReturnAfter":"1.14%","FiveDayReturnBefore":"4.27%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-09","Type":"RatingNeutral","Title":"Lazard downgrades PCLN to Neutral.","DailyReturn":"-0.01%","FiveDayReturnAfter":"2.28%","FiveDayReturnBefore":"-13.4%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Barclays maintains PCLN to Overweight. Target Price is $725; previously $800.","DailyReturn":"-17.28%","FiveDayReturnAfter":"-18.55%","FiveDayReturnBefore":"2.69%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Benchmark maintains PCLN to Buy. Target Price is $725; previously $840.","DailyReturn":"-17.28%","FiveDayReturnAfter":"-18.55%","FiveDayReturnBefore":"2.69%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Citigroup maintains PCLN to Buy. Target Price is $740; previously $850.","DailyReturn":"-17.28%","FiveDayReturnAfter":"-18.55%","FiveDayReturnBefore":"2.69%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Buy. Target Price is $760; previously $860.","DailyReturn":"-17.28%","FiveDayReturnAfter":"-18.55%","FiveDayReturnBefore":"2.69%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $710; previously $780.","DailyReturn":"-17.28%","FiveDayReturnAfter":"-18.55%","FiveDayReturnBefore":"2.69%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $650; previously $770.","DailyReturn":"-17.28%","FiveDayReturnAfter":"-18.55%","FiveDayReturnBefore":"2.69%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $727; previously $820.","DailyReturn":"-17.28%","FiveDayReturnAfter":"-18.55%","FiveDayReturnBefore":"2.69%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"PiperJaffray maintains PCLN to Overweight. Target Price is $675; previously $811.","DailyReturn":"-17.28%","FiveDayReturnAfter":"-18.55%","FiveDayReturnBefore":"2.69%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $675; previously $713.","DailyReturn":"-17.28%","FiveDayReturnAfter":"-18.55%","FiveDayReturnBefore":"2.69%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Monness Crespi Hardt downgrades PCLN to Neutral from Buy.","DailyReturn":"-17.28%","FiveDayReturnAfter":"-18.55%","FiveDayReturnBefore":"2.69%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Bank of America downgrades PCLN to Neutral from Buy. Target Price is $615; previously $790.","DailyReturn":"-17.28%","FiveDayReturnAfter":"-18.55%","FiveDayReturnBefore":"2.69%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades PCLN to Hold from Buy.","DailyReturn":"-17.28%","FiveDayReturnAfter":"-18.55%","FiveDayReturnBefore":"2.69%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-07","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.2%","FiveDayReturnAfter":"-16.84%","FiveDayReturnBefore":"-2.58%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.2%","FiveDayReturnAfter":"-16.84%","FiveDayReturnBefore":"-2.58%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-07","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"2.2%","FiveDayReturnAfter":"-16.84%","FiveDayReturnBefore":"-2.58%"},{"Ticker":"PCLN","EffectiveDate":"2012-08-07","Type":"EarningsBeatRevenueMiss","Title":"PCLN reports 2012 Q2's earning $7.85 per share and revenue $1330MM. This beats analyst's estimated EPS $7.37, misses estimated revenue $1350MM.","DailyReturn":"2.2%","FiveDayReturnAfter":"-16.84%","FiveDayReturnBefore":"-2.58%"},{"Ticker":"PCLN","EffectiveDate":"2012-07-31","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-3.04%","FiveDayReturnAfter":"-2.58%","FiveDayReturnBefore":"1.98%"},{"Ticker":"PCLN","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $822; previously $820.","DailyReturn":"2.59%","FiveDayReturnAfter":"-3.83%","FiveDayReturnBefore":"1.38%"},{"Ticker":"PCLN","EffectiveDate":"2012-06-07","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-0.98%","FiveDayReturnAfter":"0.61%","FiveDayReturnBefore":"0.74%"},{"Ticker":"PCLN","EffectiveDate":"2012-06-06","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $770; previously $810.","DailyReturn":"3.65%","FiveDayReturnAfter":"4.28%","FiveDayReturnBefore":"-5.98%"},{"Ticker":"PCLN","EffectiveDate":"2012-05-09","Type":"EarningsRelease","Title":"After market close, PCLN reports 2012 Q1's earning $3.54 per share and revenue $1037MM..","DailyReturn":"0.38%","FiveDayReturnAfter":"-7.81%","FiveDayReturnBefore":"-5.29%"},{"Ticker":"PCLN","EffectiveDate":"2012-05-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.38%","FiveDayReturnAfter":"-7.81%","FiveDayReturnBefore":"-5.29%"},{"Ticker":"PCLN","EffectiveDate":"2012-05-09","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.38%","FiveDayReturnAfter":"-7.81%","FiveDayReturnBefore":"-5.29%"},{"Ticker":"PCLN","EffectiveDate":"2012-05-09","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"0.38%","FiveDayReturnAfter":"-7.81%","FiveDayReturnBefore":"-5.29%"},{"Ticker":"PCLN","EffectiveDate":"2012-05-07","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $810; previously $730.","DailyReturn":"0.21%","FiveDayReturnAfter":"-8.6%","FiveDayReturnBefore":"-3.47%"},{"Ticker":"PCLN","EffectiveDate":"2012-04-27","Type":"RatingNeutral","Title":"Bank oferica maintains PCLN to Buy. Target Price is $800; previously $740.","DailyReturn":"3.93%","FiveDayReturnAfter":"2.22%","FiveDayReturnBefore":"2.21%"},{"Ticker":"PCLN","EffectiveDate":"2012-04-11","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Buy. Target Price is $875; previously $700.","DailyReturn":"-1.57%","FiveDayReturnAfter":"-3.55%","FiveDayReturnBefore":"2.91%"},{"Ticker":"PCLN","EffectiveDate":"2012-04-11","Type":"RatingNeutral","Title":"Benchmark maintains PCLN to Buy. Target Price is $840; previously $692.","DailyReturn":"-1.57%","FiveDayReturnAfter":"-3.55%","FiveDayReturnBefore":"2.91%"},{"Ticker":"PCLN","EffectiveDate":"2012-04-10","Type":"RatingNeutral","Title":"Cowen & Co. initiates coverage on PCLN to Outperform.","DailyReturn":"-3.07%","FiveDayReturnAfter":"-8.56%","FiveDayReturnBefore":"6.37%"},{"Ticker":"PCLN","EffectiveDate":"2012-03-26","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"2.85%","FiveDayReturnAfter":"0.35%","FiveDayReturnBefore":"5.68%"},{"Ticker":"PCLN","EffectiveDate":"2012-03-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.85%","FiveDayReturnAfter":"0.35%","FiveDayReturnBefore":"5.68%"},{"Ticker":"PCLN","EffectiveDate":"2012-03-22","Type":"RatingNeutral","Title":"PiperJaffray maintains PCLN to Overweight. Target Price is $763; previously $727.","DailyReturn":"1.18%","FiveDayReturnAfter":"2.04%","FiveDayReturnBefore":"7.81%"},{"Ticker":"PCLN","EffectiveDate":"2012-03-16","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $775; previously $725.","DailyReturn":"2.77%","FiveDayReturnAfter":"7.99%","FiveDayReturnBefore":"0.52%"},{"Ticker":"PCLN","EffectiveDate":"2012-03-07","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":"1.88%","FiveDayReturnAfter":"3.74%","FiveDayReturnBefore":"-0.47%"},{"Ticker":"PCLN","EffectiveDate":"2012-03-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.88%","FiveDayReturnAfter":"3.74%","FiveDayReturnBefore":"-0.47%"},{"Ticker":"PCLN","EffectiveDate":"2012-03-07","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"1.88%","FiveDayReturnAfter":"3.74%","FiveDayReturnBefore":"-0.47%"},{"Ticker":"PCLN","EffectiveDate":"2012-03-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.88%","FiveDayReturnAfter":"3.74%","FiveDayReturnBefore":"-0.47%"},{"Ticker":"PCLN","EffectiveDate":"2012-03-07","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"1.88%","FiveDayReturnAfter":"3.74%","FiveDayReturnBefore":"-0.47%"},{"Ticker":"PCLN","EffectiveDate":"2012-03-06","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-2.01%","FiveDayReturnAfter":"1.27%","FiveDayReturnBefore":"8.29%"},{"Ticker":"PCLN","EffectiveDate":"2012-03-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.01%","FiveDayReturnAfter":"1.27%","FiveDayReturnBefore":"8.29%"},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $695; previously $590.","DailyReturn":"6.96%","FiveDayReturnAfter":"8.29%","FiveDayReturnBefore":"1.53%"},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"PiperJaffray maintains PCLN to Overweight. Target Price is $727; previously $670.","DailyReturn":"6.96%","FiveDayReturnAfter":"8.29%","FiveDayReturnBefore":"1.53%"},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"Morgan Keegan maintains PCLN to Outperform. Target Price is $730; previously $625.","DailyReturn":"6.96%","FiveDayReturnAfter":"8.29%","FiveDayReturnBefore":"1.53%"},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"Citigroup maintains PCLN to Buy. Target Price is $850; previously $700.","DailyReturn":"6.96%","FiveDayReturnAfter":"8.29%","FiveDayReturnBefore":"1.53%"},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"Evercore Partners maintains PCLN to Equal-Weight. Target Price is $570; previously $540.","DailyReturn":"6.96%","FiveDayReturnAfter":"8.29%","FiveDayReturnBefore":"1.53%"},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"UBS maintains PCLN to Neutral. Target Price is $680; previously $550.","DailyReturn":"6.96%","FiveDayReturnAfter":"8.29%","FiveDayReturnBefore":"1.53%"},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $725; previously $690.","DailyReturn":"6.96%","FiveDayReturnAfter":"8.29%","FiveDayReturnBefore":"1.53%"},{"Ticker":"PCLN","EffectiveDate":"2012-02-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.19%","FiveDayReturnAfter":"8.97%","FiveDayReturnBefore":"3.28%"},{"Ticker":"PCLN","EffectiveDate":"2012-02-27","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.19%","FiveDayReturnAfter":"8.97%","FiveDayReturnBefore":"3.28%"},{"Ticker":"PCLN","EffectiveDate":"2012-02-27","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"0.19%","FiveDayReturnAfter":"8.97%","FiveDayReturnBefore":"3.28%"}];